1 completed, 1 unknown, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Limerick BioPharma: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, PK, and PD of LIM-0705 in Subjects With Impaired Glucose Tolerance or Abnormal HOMA-IR LIM-0705, Placebo capsules - Impaired Glucose Tolerance, Insulin Resistance | Phase 2 | Unknown | Limerick BioPharma | 50 | 2011-05-01 | 2011-06-02 |
| Investigation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LIM-0705 in Male Subjects With Impaired Glucose Tolerance LIM-0705, Placebo - Impaired Glucose Tolerance | Phase 1 | Withdrawn | Limerick BioPharma | 30 | 2010-03-01 | 2010-06-08 |
| Safety and Tolerability of LIM-0705 in Healthy Male Subjects LIM-0705 and tacrolimus, Placebo LIM-0705 and tacrolimus, Drug LIM-0705 and placebo tacrolimus - Healthy | Phase 1 | Completed | Limerick BioPharma | 44 | 2010-02-01 | 2010-06-07 |
Glucose Intolerance (2) · Insulin Resistance (1)
Tacrolimus (1)
Australia (1) · United States (1)
Albert Frauman, MD (2) · Linda Morrow, MD (1)